Sanjita Chanu, a weightlifter from India who has won the Commonwealth Games twice, has been banned for four years by the National Anti-Doping Agency (NADA) of India after she tested positive for banned drugs. The testing took place during the National Games held in Gujarat in September-October 2022, and the results showed the presence of drostanolone, an anabolic-androgenic steroid prohibited by the World Anti-Doping Agency (WADA).
Drostanolone is mainly prescribed to treat advanced inoperable breast cancer in women, but it is commonly abused by athletes as a performance-enhancing drug. The primary medical purpose of drostanolone is to treat advanced inoperable breast cancer in women. Nevertheless, athletes often misuse the steroid as a performance-enhancing drug. Following her positive test for drostanolone, Sanjita Chanu was temporarily suspended by NADA from the date of her sample collection, and her four-year suspension has now been formally declared. Consequently, Chanu will be stripped of her silver medal from the National Games as well.
After testing positive for drostanolone, Sanjita Chanu was provisionally suspended by NADA from the date of her sample collection, and her four-year ban has now been officially announced. As a result, Chanu will also lose her National Games silver medal. In the past year, several Indian athletes who had qualified for the Tokyo Olympics, including Shivpal Singh, Kamalpreet Kaur, and Dhanalakshmi Sekar, along with Commonwealth Games bronze medalist Navjeet Kaur Dhillon and promising long jumper Aishwarya Babu, were found to have violated anti-doping regulations.
Important takeaways for all competitive exams:
- National Anti-Doping Agency Headquarters: New Delhi;
- National Anti-Doping Agency Founded: 24 November 2005.